Hypoxia-Specific Tumor Labeling Protocol
Corresponding Organization :
Other organizations : University of Münster, Max Planck Institute for Molecular Biomedicine
Variable analysis
- Dose of pimonidazole (Hypoxyprobe™-1) administered intravenously (60 mg/kg bodyweight)
- Pimonidazole-adduct formation and localization in hypoxic tissue areas
- Visualization of pimonidazole-adducts by LSFM
- Time between pimonidazole injection and animal perfusion (30 minutes)
- Use of isotonic saline as the vehicle for pimonidazole dilution
- Counterstaining of pimonidazole-adducts using ATTO 594-labelled rat monoclonal α-pimonidazole antibody
- Tissue sample preparation (1 mm vibratome sections or intact BVZ-treated tumor xenograft)
- Not explicitly mentioned
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!